Cardiomyopathy Tissue Bank in a Cancer Population
试验速览
- 阶段
- 不适用
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Identification biological markers predisposing cancer patients to development of chemotherapy-induced congestive heart failure
研究概览
简要总结
Any time the words "you," "your," "I," or "me" appear, it is meant to apply to the potential participant.
The goal of this laboratory research study is to collect and store blood and tissue from patients who have a diagnosis of heart disease and may be at a high risk for the development of heart failure. This blood may be used in the future to identify genes that may play a role in developing congestive heart failure (CHF) from chemotherapy or other sources.
This is an investigational study. All will be enrolled at MD Anderson.
详细描述
You will have a one time blood draw of 2 teaspoons of blood for use in future research. This blood may be studied in the future to try to find possible genetic or biochemical markers that may be the cause of CHF. Your blood will be drawn either on an outpatient basis or during a routine visit to the hospital. If you already have a central line or an IV placed, the blood will be drawn at these sites to decrease the pain and discomfort of the blood draw. The information obtained in this study will not be put into your medical records.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 2 Months 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who are at high risk for developing Cardiomyopathy or Congestive Heart Failure.
- •Patients two months of age and older.
排除标准
- •Those that are not willing to sign an informed consent.
结局指标
主要结局
Identification biological markers predisposing cancer patients to development of chemotherapy-induced congestive heart failure
时间窗: One time visit for collection of blood and tissue samples.
Baseline Patient Demographic Information (age, sex, race)
时间窗: One time visit.
次要结局
未报告次要终点